← Back

CoroLogic

Seoul, South Korea

seedFreshly fundedMedtechAI & MLAI Infrastructure

Stage

seed

Location

Seoul, South Korea

Founded

2026

Team size

1-10

Links

About CoroLogic

Cardiovascular imaging artificial intelligence startup developing real-time generative reconstruction technology for lower-dose coronary angiography.

What sets it apart

Uses generative AI frame interpolation and an on-prem edge workflow to restore lower-frame-rate coronary angiography in real time without hardware changes.

Sectors

MedtechAI & MLAI Infrastructuremedical imaging

Business

Modelsoftware

CustomerHospitals and cardiovascular care centers performing coronary angiography, especially cath labs

Notable

  • Raised seed funding from Kakao Ventures and Seoul National University Tech Holdings
  • Completed Korean regulatory registration for its first medical device, Angio-FILM
  • Founded by a team led by a cardiology professor at Seoul National University Bundang Hospital

Backing funds on Raise

Funding rounds

16 Sept 2026

Led by Kakao Ventures

With Seoul National University Tech Holdings

Source ↗

Explore the market

FAQ

What does CoroLogic do?

Cardiovascular imaging artificial intelligence startup developing real-time generative reconstruction technology for lower-dose coronary angiography.

Where is CoroLogic based?

CoroLogic is based in Seoul, South Korea, founded in 2026.

Who has invested in CoroLogic?

Investors in CoroLogic include Kakao Ventures and Seoul National University Tech Holdings.